Home
Technology
Cardioids
Publications
Platform
Disease Models
Assays
Automation
Data Analysis
Quality Control
Case Studies
Drug Discovery
Pipeline
Cardiomyopathies
Myocardial Fibrosis
Discovery Strategy
Partnering Strategy
About
Mission
Management
Scientific Advisory
Supervisory
Partners
News
Press Releases
In The Media
Conferences
Careers
Contact
Menu
Archive
In The Media
Galen Growth
HealthTech 250: The Most Promising Early-Stage Digital Health Ventures of 2025
Zefyron
Top 10 Early-Stage Life Sciences Startups
EU-Startups
10 Fast-Growing Austrian Startups to Watch Closely in 2025
StartUs Insights
Discover 20 Innovative Pharma Startups to Watch (2024)
Startup Stash
40 Best Austrian Startups to Watch in 2024
Die Macher
Verantwortung übernehmen, nachhaltig investieren
Molecular Devices
Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries
Die Presse
In Laborschalen wachsen Herzkammern im Miniformat. Die Technik bildet menschliche Organe nach und kann in der Forschung den Einsatz von Tierexperimenten verringern
Transkript
HeartBeat.bio erhöht den Kooperationstakt
European Biotechnology
HeartBeat.bio inks partnership with Molecular Devices
Platform Life Sciences
Vienna Calling!
EU-Startups
10 super promising Vienna-based startups to watch in 2021 and beyond
Bio TechScope
First human self-organising cardioids set to revolutionise heart disease research
GEN
Self-Organizing, Beating Chambered Human Heart Cardioids Offer New Model for Research
